Dr. Boohaker is the study director for the oncology department. She designs, oversees, executes and interprets all cancer-related in vivo studies to evaluate potential cancer treatments, including cancer-fighting viruses and other agents that might help combat the disease. Trained primarily as a molecular biologist, Dr. Boohaker’s graduate work at the University of Central Florida resulted in a targeted peptide therapy to combat triple negative breast cancer. Since joining Southern Research, her recent work has focused on chemo-resistant colorectal cancers, as well as pancreatic cancers, which are aggressive and highly resistant to treatment.
Dr. Boohaker received a bachelor’s degree in biology from the University of Alabama at Birmingham and a doctorate in biomedical sciences from the University of Central Florida. Her postdoctoral work at Southern Research focused on cancer biology and DNA damage repair.
